Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Characterizing tumor shrinkage as a measure of clinical benefit for immune checkpoint inhibitors.
J Immunother Cancer. 2021 Feb;9(2):e001177. doi: 10.1136/jitc-2020-001177.
J Immunother Cancer. 2021.
PMID: 33558277
Free PMC article.
Phase III trial of FOLFOX plus bevacizumab or cediranib (AZD2171) as first-line treatment of patients with metastatic colorectal cancer: HORIZON III.
Robertson JD, Botwood NA, Rothenberg ML, Schmoll HJ.
Robertson JD, et al. Among authors: botwood na.
Clin Colorectal Cancer. 2009 Jan;8(1):59-60. doi: 10.3816/CCC.2009.n.010.
Clin Colorectal Cancer. 2009.
PMID: 19203899
Clinical Trial.
Item in Clipboard
Cite
Cite